Giift backed by Apis Partners Rebrands as Xoxoday Globally SINGAPORE, March 4, 2025 /PRNewswire/ — Giift, a leading global AI-powered loyalty… CISION PRNewswireMarch 4, 2025
Press ReleaseHuawei Unveils the AI WAN Solution, Accelerating Transition to the Net5.5G Intelligent Network Era BARCELONA, Spain, March 4, 2025 /PRNewswire/ — At MWC Barcelona 2025, Leon… CISION PRNewswireMarch 4, 2025
"Sanpoku Bio-Regional Park" to Launch in May in Northeastern Japan MURAKAMI, Japan, March 4, 2025 /PRNewswire/ — The Sanpoku Revitalization Council will launch… CISION PRNewswireMarch 4, 2025
Press ReleaseMVGX and World Free Zones Organization Partner to Advance Sustainability in Free Zones Worldwide SINGAPORE, March 4, 2025 /PRNewswire/ — MVGX Tech Pte Ltd (MVGX), a… CISION PRNewswireMarch 4, 2025
Press ReleaseFiberHome Shines at MWC 2025: Pioneering a Bright Digital Future BARCELONA, Spain, March 4, 2025 /PRNewswire/ — The global spotlight turned to… CISION PRNewswireMarch 4, 2025
Ribbon Expands Portfolio of Innovative, Cost Efficient Routers NPT 2714 and NPT 2705 deliver increased network flexibility and investment protection… CISION PRNewswireMarch 4, 2025
Digital Domain and TOPPAN Holdings Launch Collaboration on Virtual Human Solutions Utilizing biometric data from real-world people to create high-quality virtual humans that… CISION PRNewswireMarch 4, 2025
Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA® STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications… CISION PRNewswireMarch 4, 2025
